# Redefining Immune Dynamics in Acute Pancreatitis: The Protective Role of Galectin-3 Deletion and Treg Cell Enhancement

**Authors:** Ivana Milivojcevic Bevc, Danijela Tasic-Uros, Bojana S. Stojanovic, Ivan Jovanovic, Milica Dimitrijevic Stojanovic, Nevena Gajovic, Milena Jurisevic, Gordana Radosavljevic, Jelena Pantic, Bojan Stojanovic

PMC · DOI: 10.3390/biom14060642 · 2024-05-30

## TL;DR

Deleting Galectin-3 reduces inflammation and improves outcomes in acute pancreatitis by boosting protective immune cells.

## Contribution

Galectin-3 deletion is shown to reduce inflammation and enhance regulatory T cells in acute pancreatitis.

## Key findings

- Galectin-3 deficiency lowers CD3+CD49− T cells and CD4+ T helper cells in pancreatitis.
- Galectin-3 deletion increases IL-10-producing Foxp3+ T regulatory cells and reduces lung damage.
- Deleting Galectin-3 lowers serum amylase and pancreatic trypsin activity in diseased mice.

## Abstract

Acute pancreatitis (AP) is a complex inflammatory condition that can lead to systemic inflammatory responses and multiple organ dysfunction. This study investigates the role of Galectin-3 (Gal-3), a β-galactoside-binding lectin, in modulating acquired immune responses in AP. Acute pancreatitis was induced by ligation of the bile-pancreatic duct in wild-type and Galectin-3-deficient C57BL/6 mice. We determined the phenotypic and molecular features of inflammatory cells, serum concentrations of amylase, pancreatic trypsin activity, and pancreatic and lung pathology. Galectin-3 deficiency decreased the total number of CD3+CD49− T cells and CD4+ T helper cells, downregulated the production of inflammatory cytokine and IFN-γ, and increased the accumulation of IL-10-producing Foxp3+ T regulatory cells and regulatory CD4+ T cells in the pancreata of diseased animals. The deletion of Galectin-3 ameliorates acute pancreatitis characterized by lowering serum amylase concentration and pancreatic trypsin activity, and attenuating of the histopathology of the lung. These findings shed light on the role of Galectin-3 in acquired immune response in acute pancreatitis and identify Galectin-3 as an attractive target for investigation of the immunopathogenesis of disease and for consideration as a potential therapeutic target for patients with acute inflammatory disease of the pancreas.

## Linked entities

- **Genes:** LGALS3 (galectin 3) [NCBI Gene 373917]
- **Proteins:** cd.3 (Cd.3 conserved hypothetical protein), CD4 (CD4 molecule), IFNG (interferon gamma), IL10 (interleukin 10), FOXP3 (forkhead box P3)
- **Diseases:** acute pancreatitis (MONDO:0006515)

## Full-text entities

- **Genes:** IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, LGALS3 (galectin 3) [NCBI Gene 3958] {aka CBP35, GAL3, GALBP, GALIG, L31, LGALS2}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, LGALS16 (galectin 16) [NCBI Gene 148003], CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** acute inflammatory disease of the pancreas (MESH:D020275), AP (MESH:D010195), multiple organ dysfunction (MESH:D009102), lung (MESH:D008171), inflammatory (MESH:D007249)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11201657/full.md

---
Source: https://tomesphere.com/paper/PMC11201657